Utpal Basu

Utpal Basu

Auto-generated profile, based on publicly available information

Utpal Basu

Department of Molecular Biology & Biotechnology, University of Kalyani, Kalyani, India

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Materials Science and Engineering: B
Verified
Journal Article
Closed access
Swarup RoySwarup Roy
Swarup Roy
TDTapan Kumar Das
Tapan Kumar Das
GMGuru Maiti
Guru Maiti
UBUtpal Basu
Utpal Basu

27 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
UBUtpal Basu
Utpal Basu
OLOlga Lozynska
Olga Lozynska
CMCatherine Moorwood
Catherine Moorwood
GPGopal Patel
Gopal Patel
SWSteve Wilton
Steve Wilton
TKTejvir S Khurana
Tejvir S Khurana
Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne Muscular Dystrophy (DMD) locus. Its regulation is of therapeutic interest as its overexpression can compensate for dystrophin's absence in animal models of DMD. The tissue distribution and transcriptional regulation of utrophin have been characterized extensively, and more recently translational control mechanisms that may underlie its complex expression patterns have begun to be identified. Using a variety of bioinformatic, molecular and cell biology techniques, we show that the muscle isoform utrophin-A is predominantly suppressed at the translational level in C2C12 myoblasts. The extent of translational inhibition is estimated to be ∼99% in C2C12 cells and is mediated by both the 5′- and 3′-UTRs of the utrophin-A mRNA. In this study we identify five miRNAs (let-7c, miR-150, miR-196b, miR-296-5p, miR-133b) that mediate the repression, and confirm repression by the previously identified miR-206. We demonstrate that this translational repression can be overcome by blocking the actions of miRNAs, resulting in an increased level of utrophin protein in C2C12 cells. The present study has identified key inhibitory mechanisms featuring miRNAs that regulate utrophin expression, and demonstrated that these mechanisms can be targeted to increase endogenous utrophin expression in cultured muscle cells. We suggest that miRNA-mediated inhibitory mechanisms could be targeted by methods similar to those described here as a novel strategy to increase utrophin expression as a therapy for DMD.

22 August 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
SASk Tousif Ahamed
Sk Tousif Ahamed
BRBanibrata Roy
Banibrata Roy
UBUtpal Basu
Utpal Basu
SDShanta Dutta
Shanta Dutta
AGA. N. Ghosh
A. N. Ghosh
NGNabanita Giri
Nabanita Giri
Shigellosis is a public health threat in developed as well as developing countries like India. While antibiotic therapy is the mainstay of treatment for shigellosis, current emergence of multidrug-resistant strains of Shigella spp. has posed the problem more challenging. Lytic bacteriophages which destroy antibiotic resistant Shigella spp. have great potential in this context. In this study we presented the isolation and a detailed characterization of a novel bacteriophage Sfin-1, which shows potent lytic activity against multidrug-resistant isolates of Shigella flexneri, Shigella dysenteriae, Shigella sonnei obtained from clinical specimens from shigellosis patients. It is also active against Escherichia coli C. The purified phage is lytic in nature, exhibited rapid absorption (within 5-10 mins.), a short latent period (within 5-20 mins.) and relatively large (~28 to~146 PFU/cell) burst size. The isolated phage shows stability in a broad pH range and survives an hour at 50°C. Genome sequencing and phylogenetic analyses showed that Sfin-1 is a novel bacteriophage, which is very closely related to T1-like phages. In silico analysis indicates that Sfin-1 genome consists of double stranded linear DNA of 50,403 bp (GC content of 45.2%) encoding 81 potential CDSs, several potential promoters and transcriptional terminators. Under Electron microscopy, Sfin-1 shows morphology characteristics of the family Siphoviridae with an isometric head (61 nm) and a non-contractile tail (155 nm). This is most likely the first report of a lytic bacteriophage that is active against three of the most virulent multidrug-resistant Shigella species and therefore might have a potential role in phage therapy of patients infected with these organisms.

2 June 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
ARAnupam Roy
Anupam Roy
Biswatrish SarkarBiswatrish Sarkar
Biswatrish Sarkar
CCCagla Celik
Cagla Celik
AGAnimesh Ghosh
Animesh Ghosh
UBUtpal Basu
Utpal Basu
IOIsmail Ocsoy
Ismail Ocsoy

1 May 2017 in Environmental and Experimental Botany
Verified
Journal Article
Closed access
SGSupriya Ghosh
Supriya Ghosh
Kashmir SinghKashmir Singh
Kashmir Singh
ASArun K. Shaw
Arun K. Shaw
IAIkbal Azahar
Ikbal Azahar
SASinchan Adhikari
Sinchan Adhikari
ZHZahed Hossain
Zahed Hossain

1 August 2007 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
KPKelly J. Perkins
Kelly J. Perkins
UBUtpal Basu
Utpal Basu
MBMurat T. Budak
Murat T. Budak
CKCaroline Ketterer
Caroline Ketterer
SBSanthosh M. Baby
Santhosh M. Baby
TKTejvir S. Khurana
Tejvir S. Khurana
Utrophin is the autosomal homologue of dystrophin, the protein product of the Duchenne's muscular dystrophy (DMD) locus. Utrophin expression is temporally and spatially regulated being developmentally down-regulated perinatally and enriched at neuromuscular junctions (NMJs) in adult muscle. Synaptic localization of utrophin occurs in part by heregulin-mediated extracellular signal-regulated kinase (ERK)-phosphorylation, leading to binding of GABPα/β to the N-box/EBS and activation of the major utrophin promoter-A expressed in myofibers. However, molecular mechanisms contributing to concurrent extrasynaptic silencing that must occur to achieve NMJ localization are unknown. We demonstrate that the Ets-2 repressor factor (ERF) represses extrasynaptic utrophin-A in muscle. Gel shift and chromatin immunoprecipitation studies demonstrated physical association of ERF with the utrophin-A promoter N-box/EBS site. ERF overexpression repressed utrophin-A promoter activity; conversely, small interfering RNA-mediated ERF knockdown enhanced promoter activity as well as endogenous utrophin mRNA levels in cultured muscle cells in vitro. Laser-capture microscopy of tibialis anterior NMJ and extrasynaptic transcriptomes and gene transfer studies provide spatial and direct evidence, respectively, for ERF-mediated utrophin repression in vivo. Together, these studies suggest “repressing repressors” as a potential strategy for achieving utrophin up-regulation in DMD, and they provide a model for utrophin-A regulation in muscle.